Topaloglu O - Search Results

1

Epigenetic silencing of S100A2 in bladder and head and neck cancers.

Lee J, Wysocki PT, Topaloglu O, Maldonado L, Brait M, Begum S, Moon D, Kim MS, Califano JA, Sidransky D, Hoque MO, Moon C. Lee J, et al. Among authors: topaloglu o. Oncoscience. 2015 Mar 16;2(4):410-8. doi: 10.18632/oncoscience.140. eCollection 2015. Oncoscience. 2015. PMID: 26097874 Free PMC article.

2

Detection of promoter hypermethylation of multiple genes in the tumor and bronchoalveolar lavage of patients with lung cancer.

Topaloglu O, Hoque MO, Tokumaru Y, Lee J, Ratovitski E, Sidransky D, Moon CS. Topaloglu O, et al. Clin Cancer Res. 2004 Apr 1;10(7):2284-8. doi: 10.1158/1078-0432.ccr-1111-3. Clin Cancer Res. 2004. PMID: 15073103

3

Quantitative detection of promoter hypermethylation of multiple genes in the tumor, urine, and serum DNA of patients with renal cancer.

Hoque MO, Begum S, Topaloglu O, Jeronimo C, Mambo E, Westra WH, Califano JA, Sidransky D. Hoque MO, et al. Among authors: topaloglu o. Cancer Res. 2004 Aug 1;64(15):5511-7. doi: 10.1158/0008-5472.CAN-04-0799. Cancer Res. 2004. PMID: 15289362

4

Quantitative methylation-specific polymerase chain reaction gene patterns in urine sediment distinguish prostate cancer patients from control subjects.

Hoque MO, Topaloglu O, Begum S, Henrique R, Rosenbaum E, Van Criekinge W, Westra WH, Sidransky D. Hoque MO, et al. Among authors: topaloglu o. J Clin Oncol. 2005 Sep 20;23(27):6569-75. doi: 10.1200/JCO.2005.07.009. J Clin Oncol. 2005. PMID: 16170165

5

Quantitation of promoter methylation of multiple genes in urine DNA and bladder cancer detection.

Hoque MO, Begum S, Topaloglu O, Chatterjee A, Rosenbaum E, Van Criekinge W, Westra WH, Schoenberg M, Zahurak M, Goodman SN, Sidransky D. Hoque MO, et al. Among authors: topaloglu o. J Natl Cancer Inst. 2006 Jul 19;98(14):996-1004. doi: 10.1093/jnci/djj265. J Natl Cancer Inst. 2006. PMID: 16849682

6

P63 alpha mutations lead to aberrant splicing of keratinocyte growth factor receptor in the Hay-Wells syndrome.

Fomenkov A, Huang YP, Topaloglu O, Brechman A, Osada M, Fomenkova T, Yuriditsky E, Trink B, Sidransky D, Ratovitski E. Fomenkov A, et al. Among authors: topaloglu o. J Biol Chem. 2003 Jun 27;278(26):23906-14. doi: 10.1074/jbc.M300746200. Epub 2003 Apr 10. J Biol Chem. 2003. PMID: 12692135 Free article.

7

A dimeric peptide that binds selectively to prostate-specific membrane antigen and inhibits its enzymatic activity.

Aggarwal S, Singh P, Topaloglu O, Isaacs JT, Denmeade SR. Aggarwal S, et al. Among authors: topaloglu o. Cancer Res. 2006 Sep 15;66(18):9171-7. doi: 10.1158/0008-5472.CAN-06-1520. Cancer Res. 2006. PMID: 16982760

8

Digital HLA allelotyping.

Topaloglu O, Civin CI, Bunz F. Topaloglu O, et al. Cancer Biol Ther. 2004 Sep;3(9):899-902. doi: 10.4161/cbt.3.9.1083. Epub 2004 Sep 15. Cancer Biol Ther. 2004. PMID: 15326386

9

Improved methods for the generation of human gene knockout and knockin cell lines.

Topaloglu O, Hurley PJ, Yildirim O, Civin CI, Bunz F. Topaloglu O, et al. Nucleic Acids Res. 2005 Oct 7;33(18):e158. doi: 10.1093/nar/gni160. Nucleic Acids Res. 2005. PMID: 16214806 Free PMC article.

10

Deficiency of Bloom syndrome helicase activity is radiomimetic.

Horowitz DP, Topaloglu O, Zhang Y, Bunz F. Horowitz DP, et al. Among authors: topaloglu o. Cancer Biol Ther. 2008 Nov;7(11):1783-6. doi: 10.4161/cbt.7.11.6779. Epub 2008 Nov 4. Cancer Biol Ther. 2008. PMID: 18787401 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

140 results

Search Page